A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System (PARACHUTE IV)
Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
Sponsor: CardioKinetix, Inc
Terminated
Company is closed
Other terminated trials from CardioKinetix, Inc
- Heart Failure · Phase PHASE3 · Jun 2017
- Heart Failure · Jun 2017
- Ischemic Heart Failure · Phase NA · Jun 2017
- Heart Failure · Jun 2017
- Heart Failure · Jun 2017
More terminations from CardioKinetix, Inc
Other Congestive Heart Failure trials with similar outcome
A PHASE3 clinical study on Congestive Heart Failure and Left Ventricular (LV) Systolic Dysfunction, this trial is terminated or withdrawn. The trial is conducted by CardioKinetix, Inc and has accumulated 8 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
-
Jul 2017 — Jun 2018 [monthly]
Terminated PHASE3
Status: Active Not Recruiting → Terminated
▶ Show 3 earlier versions
-
May 2017 — Jul 2017 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — May 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Dec 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CardioKinetix, Inc
For direct contact, visit the study record on ClinicalTrials.gov .